Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients

被引：2
|
作者：
Takezako, Naoki [1 ]
Tokuhira, Michihide [2 ]
Sekiguchi, Naohiro [1 ]
Kizaki, Masahiro [2 ]
机构：
[1] Disaster Med Ctr, Tachikawa, Tokyo, Japan
[2] Saitama Med Ctr, Saitama, Japan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.257
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-255
引用
收藏
页码：E142 / E143
页数：2
相关论文
共 50 条
  • [21] A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older Than 65 Years
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez, Joaquin
    Teresa Cibeira, Ma
    Gutierrez, Norma C.
    Jose Terol, Maria
    de Paz, Raquel
    Garcia-Larana, Jose
    Bengoechea, Enrique
    Martin Garcia-Sancho, Alejandro
    Martinez, Rafael
    Palomera, Luis
    de Arriba, Felipe
    Gonzalez, Yolanda
    Hernandez, Jose
    Sureda, Anna
    Bello, Jose-Luis
    Jose Lahuerta, Juan
    Blade, Joan
    San-Miguel, Jesus F.
    BLOOD, 2009, 114 (22) : 3 - 4
  • [22] Bortezomib, melphalan, prednisone, and thalidomide (VMPT) followed by maintenance with bortezomib and thalidomide (VT) for initial treatment of elderly multiple myeloma patients
    Boccadoro, M.
    Bringhen, S.
    Gaidano, G.
    Ria, R.
    Offidani, M.
    Patriarca, F.
    Nozzoli, C.
    Musto, P.
    Petrucci, M.
    Palumbo, A. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Bortezomib-Containing Regimens for Multiple Myeloma Maintenance Therapy: a Meta-Analysis
    Wang, Yucai
    Zhang, Wenwen
    Yang, Fang
    Guan, Xiaoxiang
    Kothari, Neil
    Chang, Victor
    Wang, Michael
    BLOOD, 2014, 124 (21)
  • [24] BORTEZOMIB-MELPHALAN-PREDNISONE-THALIDOMIDE FOLLOWED BY BORTEZOMIB-THALIDOMIDE MAINTENANCE FOR INITIAL THERAPY OF MULTIPLE MYELOMA: A PROSPECTIVE RANDOMIZED TRIAL
    Palumbo, A.
    Bringhen, S.
    Rossi, D.
    Ria, R.
    Offidani, M.
    Musto, P.
    Petrucci, M. T.
    Omede, P.
    Di Raimondo, F.
    Boccadoro, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 350 - 350
  • [25] Bortezomib and Dexamethasone as Maintenance therapy in Relapse/Refractory multiple myeloma Patients.
    Benevolo, Giulia
    Larocca, Alessandra
    Pregno, Patrizia
    Gay, Francesca
    Botto, Barbara
    Orsucci, Lorella
    Evangelista, Andrea
    Palumbo, Antonio
    Vitolo, Umberto
    Boccadoro, Mario
    BLOOD, 2008, 112 (11) : 956 - 956
  • [26] EFFICACY AND SAFETY OF BORTEZOMIB-BASED RETREATMENT IN MULTIPLE MYELOMA (MM) PATIENTS RELAPSING AFTER BORTEZOMIB-CONTAINING FIRST-LINE THERAPY: A RETROSPECTIVE STUDY
    Oriol, A.
    Giraldo, P.
    Kotsianidis, I.
    Couturier, C.
    Angermund, R.
    Broer, E.
    Corso, A.
    HAEMATOLOGICA, 2012, 97 : 609 - 610
  • [27] EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS INJECTION OF BORTEZOMIB IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
    Fu, C.
    Liu, H.
    Wu, D.
    Xue, S.
    Li, W.
    Wu, Q.
    Gu, B.
    Jin, S.
    Zhu, X.
    Zhao, S.
    Xin, X.
    Ma, L.
    Sun, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S452 - S452
  • [28] Bortezomib pharmacokinetics in tumor response and peripheral neuropathy in multiple myeloma patients receiving bortezomib-containing therapy
    Lee, Sung-Eun
    Choi, Kyungmee
    Han, Seunghoon
    Lee, Jongtae
    Hong, Taegon
    Park, Gab-Jin
    Yim, Dong-Seok
    Min, Chang-Ki
    ANTI-CANCER DRUGS, 2017, 28 (06) : 660 - 668
  • [29] Efficacy and Safety of Bortezomib plus Dexamethasone Therapy for Refractory or Relapsed Multiple Myeloma: Once-weekly Administration of Bortezomib may Reduce the Incidence of Gastrointestinal Adverse Events
    Fukushima, Toshihiro
    Nakamura, Takuji
    Iwao, Haruka
    Nakajima, Akio
    Miki, Miyuki
    Sato, Tomomi
    Sakai, Tomoyuki
    Sawaki, Toshioki
    Fujita, Yoshimasa
    Tanaka, Masao
    Masaki, Yasufumi
    Nakajima, Hideo
    Motoo, Yoshiharu
    Umehara, Hisanori
    ANTICANCER RESEARCH, 2011, 31 (06) : 2297 - 2302
  • [30] A cohort study comparing the efficacy and safety of bortezomib plus dexamethasone versus bortezomib,epirubicin and dexamethasone in patients with multiple myeloma
    郝倩云
    China Medical Abstracts(Internal Medicine), 2016, 33 (04) : 230 - 230
12345